Established in 1976, Lameplast is a premium manufacturer of primary plastic single / multi-dose containers for the pharmaceutical market, with main focus on the ophthalmic segment. Lameplast is one of the leaders on the Italian and European market in the design, production and commercialization of single dose packaging with the injection and blow moulding technologies. The Company relies on 25+ years of partnership experience with blue-chip Italian and international healthcare companies.

Sector: Primary Packaging for pharmaceutical and cosmetics sectors

Investment Year: 2016

Investment type: leveraged management buy-in
Share: controlling
Revenue class (€M): 25-50 (50% exported)
Employees class: 100-250
Office: Carpi (Province of Modena)
Website: www.lameplastgroup.com

Value creation: Aksìa Group acquired Lameplast from the founding families to guide and support its business transition and further development nationally and internationally. With the help of the new management, the project envisions entry into new areas of application and expansion of the range of services offered to customers, taking advantage of the trend towards single-dose containers in the pharmaceutical and cosmetic sectors.